Review: could Colon cancer metastatic cause Rash?
We study 2,308 people who have Colon cancer metastatic from FDA and social media. Among them, 108 have Rash (Rashes). Find out below who they are, other conditions they have and drugs they take.
Stay connected: join a mobile support group for people who have Colon cancer metastatic and Rash >>>
Colon cancer metastatic
Colon cancer metastatic (latest reports from 5,885 patients) is typically treated by Xeloda.
Rash (redness) (latest reports from 969,199 patients) has been reported by people with rheumatoid arthritis, high blood pressure, high blood cholesterol, osteoporosis, depression.
On Jul, 15, 2014: 2,308 people who have colon cancer metastatic are studied. Among them, 109 (4.72%) have Rash. They amount to 0.01% of all the 969,970 people who have Rash on eHealthMe.
Gender of people who have colon cancer metastatic and experienced Rash * :
Age of people who have colon cancer metastatic and experienced Rash * :
Severity of the symptom * :
|least||moderate||severe||most severe |
Top co-existing conditions for these people * :
- Prophylaxis (46 people, 42.20%)
- Bone disorder (45 people, 41.28%)
- Pain (45 people, 41.28%)
- Hypertension (5 people, 4.59%)
- Chronic myeloid leukaemia (5 people, 4.59%)
- Deep vein thrombosis (4 people, 3.67%)
- Colon cancer (2 people, 1.83%)
- Deafness (2 people, 1.83%)
- Pruritus (1 people, 0.92%)
- Diarrhoea (1 people, 0.92%)
Most common drugs used by these people * :
- Fluorouracil (94 people, 86.24%)
- Avastin (85 people, 77.98%)
- Leucovorin calcium (72 people, 66.06%)
- Zometa (50 people, 45.87%)
- Aspirin (48 people, 44.04%)
- Erbitux (48 people, 44.04%)
- Lorazepam (46 people, 42.20%)
- Ibuprofen (45 people, 41.28%)
- Furosemide (45 people, 41.28%)
- Lortab (45 people, 41.28%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Get connected! Join a mobile support group:
- group for people who have Rash and Colon cancer metastatic
- group for people who have Colon cancer metastatic
- group for people who have Rash
Common treatments for Colon Cancer Metastatic and their efficacy:
Could your drug cause it?
Comments from related studies:
From this study (7 hours ago):
I am taking krill oil, zrytec and aspirin. All of a sudden having skin rash and very itchy skin.
From this study (2 days ago):
Purbac subscribed to treat skin rash.
From this study (5 days ago):
I have developed a rash on my upper arms, elbows, back and groin areas
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Colon cancer metastatic, Rash
You may be interested at these reviews (what is this?):
- Skin rash in diclofenac potassium
After a car accident in 2011 I took Diclofenac for back & shoulder off and on for about a year. During that time I developed random spots usually on my arms and legs that itch severely and sometimes get infected. I still suffer from the itchy spots and I am DESPERATE for a cure for my agony. I ha ...
More reviews for: Colon cancer metastatic, Rash
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.